Phase 2 Hypogammaglobulinemia Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Multiple MyelomaHypogammaglobulinemiaHypogammaglobulinemia, Acquired

Memorial Sloan Kettering Cancer Center100 enrolled8 locationsNCT06976476

Recruiting

Phase 2Phase 3

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension

Haematological MalignancyHypogammaglobulinemia

Monash University300 enrolled7 locationsNCT05678621